Search results
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks· 6 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily ...
Zymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
GuruFocus.com via Yahoo Finance· 5 days agoDespite a rise in net loss and a drop in revenue, Zymeworks Inc (ZYME) remains optimistic with strong cash reserves and strategic advancements in global clinical trials.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 1 day agoLooking at individual holdings, West Pharmaceutical Services Inc (WST) accounts for about 1.73% of...
Stocks Higher As Disney Dives On Revenue Miss
Investor's Business Daily· 1 day agoKey earnings movers include Datadog, Palantir and Vertex Pharmaceuticals.
In re Cellect Poses an Obvious Dilemma | JD Supra
JD Supra· 2 days agoIn August 2023, the Federal Circuit in In re Cellect held that in evaluating unpatentability for obviousness-type double patenting (ODP) of a patent...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 6 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Chiesi buys into Gossamer’s Winrevair rival, betting almost $500M
FierceBiotech· 2 days agoGossamer is currently enrolling a phase 3 seralutinib study for patients with PAH, the same...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 2 days agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 6 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Futures: Stocks Extend Gains; Apple Event Next
Investor's Business Daily· 2 days agoKey earnings movers late Monday include Palantir, Axon and Vertex Pharmaceuticals.